Tracy Mcgowan, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 800 Ridgeview Dr, Horsham, PA 19044 Phone: 215-325-5329 |
News Archive
Eric Goosby, head of PEPFAR, on Wednesday reemphasized the U.S. commitment to fighting HIV/AIDS globally, the Associated Press reports. Despite concerns by international aid groups that the current economic climate might force HIV/AIDS funding to be scaled back, "Goosby said President Barack Obama and Secretary of State Hillary Rodham Clinton have assured him his program remains among 'the highest priorities,'" the news service writes.
Cardinal Health and Patient Safety Technologies today announced that they have entered into a five-year exclusive distribution agreement to co-market the SurgiCount Safety-Sponge(TM) System, which helps prevent retention of sponges and towels unintentionally left in patients during surgical procedures.
The technological development has international recognition and has sparked interest for industrial production by a manufacturer in the medical sector.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTEĀ® antibodies, designed to harness the body's T cells to kill cancer cells.
A new brain imaging study of recently diagnosed schizophrenia patients has found, for the first time, that the loss of gray matter typically experienced by patients can be prevented by one of the new atypical antipsychotic drugs, olanzapine, but not by haloperidol, an older, conventional drug.
› Verified 5 days ago